We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $42.5B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+5.34%
1 Year Est. Return
+18.19%
3 Year Est. Return
+63.85%
5 Year Est. Return
+89.78%
10 Year Est. Return
+309.54%
AUM
$43.1B
AUM Growth
+$1.45B
Cap. Flow
-$96.7M
Cap. Flow %
-0.22%
Top 10 Hldgs %
45.82%
Holding
319
New
11
Increased
71
Reduced
116
Closed
14

Top Buys

Rank Stock Value
1
CVX icon
Chevron
CVX
+$194M
2
NVDA icon
NVIDIA
NVDA
+$146M
3
UNH icon
UnitedHealth
UNH
+$137M
4
META icon
Meta Platforms (Facebook)
META
+$117M
5
PM icon
Philip Morris
PM
+$68.8M

Top Sells

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$184M
2
HES
Hess
HES
+$175M
3
NKE icon
Nike
NKE
+$95.7M
4
PEP icon
PepsiCo
PEP
+$94.4M
5
AAPL icon
Apple
AAPL
+$83.3M

Sector Composition

Rank Sector Weight
1 Technology 31.75%
2 Financials 18.34%
3 Consumer Staples 10.86%
4 Healthcare 8.86%
5 Communication Services 8.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IBM icon
126
IBM
IBM
$235B
$4.95M 0.01%
17,541
-355
-2% -$92.9K
EMR icon
127
Emerson Electric
EMR
$82.7B
$4.82M 0.01%
36,739
-75
-0.2% -$10.2K
ITW icon
128
Illinois Tool Works
ITW
$76.6B
$4.78M 0.01%
18,335
-125
-0.7% -$32.6K
CARR icon
129
Carrier Global
CARR
$47.2B
$4.74M 0.01%
79,320
-620
-0.8% -$42.1K
CSX icon
130
CSX Corp
CSX
$90.6B
$4.69M 0.01%
132,000
– –
ET icon
131
Energy Transfer Partners
ET
$74B
$4.2M 0.01%
245,013
– –
WYNN icon
132
Wynn Resorts
WYNN
$9.04B
$3.94M 0.01%
30,750
– –
VRTX icon
133
Vertex Pharmaceuticals
VRTX
$132B
$3.94M 0.01%
10,058
-300
-3% -$125K
NVS icon
134
Novartis
NVS
$264B
$3.58M 0.01%
27,952
-184
-0.7% -$22.5K
EQIX icon
135
Equinix
EQIX
$98.5B
$3.46M 0.01%
4,423
– –
FOX icon
136
Fox Class B
FOX
$25.7B
$3.21M 0.01%
56,111
– –
AMD icon
137
Advanced Micro Devices
AMD
$805B
$2.96M 0.01%
18,280
+85
+0.5% +$13.7K
TSLA icon
138
Tesla
TSLA
$1.42T
$2.86M 0.01%
6,421
– –
DKNG icon
139
DraftKings
DKNG
$12.3B
$2.82M 0.01%
75,500
– –
YUMC icon
140
Yum China
YUMC
$14.5B
$2.78M 0.01%
64,686
+100
+0.2% +$4.55K
GE icon
141
GE Aerospace
GE
$329B
$2.71M 0.01%
8,996
-69
-0.8% -$18.9K
MDT icon
142
Medtronic
MDT
$120B
$2.68M 0.01%
28,123
+28
+0.1% +$2.57K
GD icon
143
General Dynamics
GD
$96.5B
$2.65M 0.01%
7,760
+39
+0.5% +$12.3K
APH icon
144
Amphenol
APH
$194B
$2.63M 0.01%
42,462
– –
BAC icon
145
Bank of America
BAC
$416B
$2.56M 0.01%
49,666
-153
-0.3% -$7.46K
CMI icon
146
Cummins
CMI
$74.5B
$2.52M 0.01%
5,975
-42
-0.7% -$16.1K
GS icon
147
Goldman Sachs
GS
$288B
$2.51M 0.01%
3,149
+14
+0.4% +$10.4K
BRCC icon
148
BRC Inc
BRCC
$128M
$2.46M 0.01%
+157,453
New +$2.52M
LRCX icon
149
Lam Research
LRCX
$342B
$2.39M 0.01%
17,834
+29
+0.2% +$3.07K
CSCO icon
150
Cisco
CSCO
$434B
$2.31M 0.01%
33,793
– –
4 5
6
7 8

Similar funds

PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
GAM
Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $41.9B AUM 18.91% 1-Year Est. Return
Newport Trust Company
Newport Trust Company Washington, District of Columbia $41.5B AUM 16.76% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Fayez Sarofim & Co's Q3 2025 Portfolio in Review

As of Q3 2025, Fayez Sarofim & Co held 319 positions worth $43.1B, up 3.5% from $41.7B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Fayez Sarofim & Co's Q3 2025 filing shows 11 new, 71 increased, 116 reduced and 14 closed positions. Its largest new stake was SAP: 49,674 shares worth $13.3M. The largest sale was Novo Nordisk, an estimated $184M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Staples.

  • Fayez Sarofim & Co's largest Q3 2025 buy was SAP: 49,674 shares worth $13.3M.
  • Fayez Sarofim & Co added most to Chevron in Q3 2025, an estimated $194M increase.
  • Fayez Sarofim & Co's biggest Q3 2025 reduction was Novo Nordisk, cutting an estimated $184M.
  • Fayez Sarofim & Co fully exited Hess in Q3 2025, selling an estimated $175M.
  • Fayez Sarofim & Co's ten largest holdings make up 46% of its $43.1B portfolio in Q3 2025.
  • Fayez Sarofim & Co opened 11 new positions and closed 14 in Q3 2025.
  • Fayez Sarofim & Co's portfolio value rose 3.5% quarter-over-quarter to $43.1B.

Based on Fayez Sarofim & Co's 13F filing for Q3 2025, filed 14 Nov 2025.